Sarah Royalty Tredo
Sarah is an accomplished biopharmaceutical leader with demonstrated ability to identify growth opportunities and execute against those opportunities. Sarah is the Global Program Lead for Emergent’s Chikungunya VLP vaccine candidate. Prior to joining Emergent, Sarah spent 10 years at Takeda Pharmaceuticals working in US and Global commercial strategies and life cycle product management, Sales, Global Business Development, and Global Project Management. Sarah has demonstrated broad therapeutic expertise, having worked directly in Gastroenterology, Pediatrics, Immunology, Vaccines, Anti-Infectives and Diabetes, while supporting alliances in other therapeutic areas. She has worked in the healthcare industry for 20 years. Sarah holds an MBA from Northwestern Kellogg and a BSBA from the University of Missouri - Columbia in the Robert J. Trulaske Sr. College of Business.